•  
  •  
  •  
  •  

2025-12-23 09:30:29

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  AbbottIndia

Stock Report

  • Abbott India Limited recommends final dividend of Rs. 475
  • Abbott India Ltd posts net profit of Rs. 367.04 crores in Q4 FY2025
  • Abbott launches 14 valent Pneumococcal Conjugate Vaccine - PCV-14
  • Abbott India Ltd posts Rs. 358.61 crores net profit in Q2 FY25
  • Abbott India Ltd non-exclusive patent license agreement with Takeda for Vonoprazan
  • Abbott India Ltd posts net profit of Rs. 287.06 crores in Q4 FY2023-24
  • Abbott India Ltd posts net profit of Rs. 310.98 crores in Q3 FY2024
  • Abbott India's Q1 FY24 PAT rises to Rs. 290.24 crores
  • Abbott India Limited recommends final dividend of Rs. 180, special dividend of Rs. 145
  • Abbott India Ltd Q4FY23 net profit at Rs. 231.42 crores
  • Abbott India reports net profit of Rs. 246.83 crores in Q3 FY23
  • Abbott India Ltd recommends final dividend of Rs. 145, special dividend of Rs. 130
  • Abbott India Q4 FY2022 net profit at Rs. 211.41 crores
  • Abbott India Q3FY22 net profit jumps to Rs. 199.20 crores
  • Abbott India Ltd announces resignation of MD
  • Abbott India Ltd Q2FY22 net profit at Rs. 192.33 crores

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024